Welcome to our dedicated page for TD SYNNEX SEC filings (Ticker: SNX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on TD SYNNEX's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into TD SYNNEX's regulatory disclosures and financial reporting.
TD SYNNEX director and officer Dennis Polk, who serves as Chair of Hyve Solutions, reported changes in his TD SYNNEX common stock holdings dated 01/20/2026. The Form 4 shows a disposition of 320 shares of common stock at a price of $146.29 per share, leaving him with 22,439 common shares held directly.
He is also reported as having 84,147 common shares held indirectly through a trust. A footnote explains this reflects the transfer of 11,340 shares from the reporting person to a revocable grantor trust, of which he is a trustee, indicating a shift of part of his holdings into a trust structure rather than a reduction in total beneficial exposure.
TD SYNNEX insider Dennis Polk reported multiple stock option exercises and related share sales. On January 12, 2026, Polk exercised stock options to acquire 3,997 common shares at $106.35 per share and employee stock options to acquire 15,372 and 631 common shares at $107.32 per share. The options vest 20% after one year from grant and then monthly in 1/60th increments.
On the same date, he sold blocks of common stock, including 7,432 shares at a weighted average price of $149.61, 631 shares at $149.67, and 11,937 shares at a weighted average price of $150.23, with detailed price breakdowns available on request. After these transactions, Polk directly held 34,099 TD SYNNEX common shares and indirectly held 72,807 shares through a trust.
TD SYNNEX Chief Legal Officer David R. Vetter reported routine equity transactions in company common stock. On January 5, 2026, he acquired 2,908 shares of TD SYNNEX common stock at $0 per share, reflecting the vesting of previously granted restricted stock units that were awarded on January 3, 2023 and tied to performance metrics measured over a three-year period ended November 30, 2025.
On the same date, a separate transaction coded “F” disposed of 763 shares at $153.14 per share. Following these transactions, Vetter directly beneficially owned 71,585 shares of TD SYNNEX common stock.
TD SYNNEX Chief Executive Officer Patrick Zammit reported equity compensation activity. On January 5, 2026, he acquired 4,299 shares of TD SYNNEX common stock at a price of $0.00 per share, representing shares issued upon vesting of restricted stock units awarded on January 3, 2023 and subject to performance metrics measured over a three-year period ended November 30, 2025.
On the same date, he disposed of 1,763 shares of common stock at $153.14 per share. After these transactions, Zammit directly owned 184,828 shares of TD SYNNEX common stock.
A shareholder of SNX has filed a Rule 144 notice to sell 20,000 shares of common stock on the NYSE through Morgan Stanley Smith Barney LLC. The planned sale, dated around 01/12/2026, has an indicated aggregate market value of $2,999,579.43, compared with 81,437,855 shares of common stock outstanding. The shares to be sold were acquired on 01/12/2026 via a stock option exercise from the issuer for cash.
Over the past three months, the POLK FAMILY TRUST U/T/A DTD 04/25/2007 has reported additional sales of SNX common stock: 3,000 shares on 11/04/2025 for $451,698.18, 3,000 shares on 12/04/2025 for $465,086.50, and 2,853 shares on 01/05/2026 for $438,754.28. The signer represents that they are not aware of undisclosed material adverse information about the issuer.
TD SYNNEX Corporation reported that it has released its financial results for the fiscal fourth quarter ended November 30, 2025. The company also announced a cash dividend of $0.48 per common share to be paid in the first quarter of its 2026 fiscal year. The details of the quarter’s performance and the dividend timing are provided in an accompanying press release.
The company furnished this information via a press release attached as an exhibit, rather than including full financial statements in this report.
TD SYNNEX CORP director reports planned stock sales on Form 4. On 01/05/2026, the reporting person, a director of TD SYNNEX, sold a total of 5,000 shares of common stock in multiple transactions. The sales were coded as open-market sales and were made under a Rule 10b5-1 trading plan that was adopted on July 14, 2025.
The shares were sold at weighted average prices ranging from about $152.81 to $156.42 across several price intervals, as detailed in the footnotes. After these transactions, the director reported owning 47,515 shares of TD SYNNEX common stock directly.
TD SYNNEX Corp insider reports planned stock sales by family trust. A director and Hyve Solutions executive of TD SYNNEX Corp filed a Form 4 disclosing multiple open-market sales of common stock on January 5, 2026. The trades were executed under a pre-arranged Rule 10b5-1 trading plan adopted on October 13, 2024 on behalf of the Polk family trust, where the insider is a trustee. The reported sales were made at weighted average prices in ranges such as $152.43–$152.94, $153.05–$153.96, $154.06–$154.80, and $155.19–$155.86, plus one sale at $156.79. Following these transactions, the trust held 72,807 shares indirectly, and the insider also held 34,099 shares directly.
TD SYNNEX Corp reported an insider transaction by a director involving a small sale of common stock. On 12/04/2025, the director sold 168 shares of TD SYNNEX common stock at a price of $153.38 per share, coded as an open-market sale. After this transaction, the director beneficially owns 7,162 shares, held directly. The filing notes that these sales were carried out under a Rule 10b5-1 trading plan adopted on August 2, 2025, which is a pre-arranged plan designed to allow insiders to trade shares according to preset instructions.
TD SYNNEX reported insider stock sales by a director and Hyve Solutions executive. On 12/04/2025, a total of 3,000 shares of common stock were sold in several transactions by a family trust, all coded as open-market sales. The shares were sold at weighted average prices of $154.47, $155.72, and $156.01, with underlying trade prices ranging from $154.17 to $155.91.
The filing notes these transactions were made under a Rule 10b5-1 trading plan adopted on October 13, 2024 for the Polk family trust, of which the insider is a trustee. After these sales, the trust indirectly holds 75,660 shares, and the insider directly holds an additional 34,099 shares of TD SYNNEX common stock.